ArticleJournal of multidisciplinary healthcare2026
Association of Hypertension and Serum Aldosterone Levels in Male Patients with Androgenetic Alopecia: A Case-Control Study.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Androgenetic alopecia (AGA), patterned hair loss driven by a genetically determined follicular sensitivity to androgens, has been linked to systemic conditions, although findings remain inconsistent. This study evaluated the association between AGA, blood pressure, and serum aldosterone levels in a hospital-based sample in Saudi Arabia. Methods: This hospital-based, single-centre case-control study involved 20 males diagnosed with AGA and 20 age-matched male controls. Blood pressure and serum aldosterone were compared using independent-samples t-tests, Mann-Whitney Results: No significant differences were found between groups in serum aldosterone (t(38) = -0.30, p = 0.766), systolic blood pressure (t(37) = -1.34, p = 0.188), or diastolic blood pressure (t(37) = -1.31, p = 0.180); effect sizes were small and confidence intervals crossed zero. Non-parametric tests and adjusted models yielded the same non-significant results. Conclusion: Our findings do not reveal association between AGA and raised blood pressure or high levels of serum aldosterone. Because of the limited sample size and the absence of renin and aldosterone-to-renin ratio measurement, these findings do not definitively rule out an association. In fact, recent systematic review and meta-analysis reported a significant AGA-hypertension association in men. Larger, adequately powered studies with complete aldosterone-renin profiling are needed to clarify the relationship between AGA and cardiovascular and endocrine health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.